Journal of Cardiac Failure
Volume 15, Issue 7 , Pages 565-571 , September 2009

Soluble Angiotensin-Converting Enzyme 2 in Human Heart Failure: Relation With Myocardial Function and Clinical Outcomes

  • Slava Epelman, MD, PhD

      Affiliations

    • Department of Medicine, Section of Cardiology, Baylor College of Medicine, Houston, Texas
    • ,
  • Kevin Shrestha, BA

      Affiliations

    • Department of Cell Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Richard W. Troughton, MBBS

      Affiliations

    • Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand
    • ,
  • Gary S. Francis, MD

      Affiliations

    • Cardiovascular Disease Division, University of Minnesota Medical School, Minneapolis, Minnesota
    • ,
  • Subha Sen, PhD, DSc

      Affiliations

    • Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Allan L. Klein, MD

      Affiliations

    • Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio
    • ,
  • W.H. Wilson Tang, MD

      Affiliations

    • Department of Cell Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio
    • Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio
    • Corresponding Author InformationReprints requests: W. H. Wilson Tang, MD, Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, J3-4, Cleveland, OH 44195. Tel: (216) 444-2121; Fax: (216) 445-6165.

Received 16 January 2009 ,Accepted 26 January 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 All decisions regarding this manuscript were made by a guest editor.

 The original Assessment of Doppler Echocardiography in Prognosis and Therapy study was supported by the 2003 American Society of Echocardiography Outcomes Research Award (Drs. Troughton and Klein), GlaxoSmithKline Pharmaceuticals, and Roche Diagnostics Inc.

PII: S1071-9164(09)00036-0

doi: 10.1016/j.cardfail.2009.01.014

Journal of Cardiac Failure
Volume 15, Issue 7 , Pages 565-571 , September 2009

Article Tools

* Image Usage & Resolution